Drawing for MEDIXMAB

USPTO serial 78862953

MEDIXMAB

Reviewed by CopyMark Law Group

Reg. 3381878Status 800Registered
Filing date
Status date
Registration date
Feb 12, 2008
Examiner
BRADLEY, EVELYN
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with MEDIXMAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roger H. Bora

Roger H. Bora THOMPSON HINE LLP10050 Innovation Drive, Suite 400Dayton, OH 45342-4934UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for medical research; reagent media for medical researchACTIVE—
005Diagnostic preparations for medical use; reagent media for medical purposes; in vitro test kits for medical and clinical use consisting primarily of reagents and processing chemicalsACTIVE—
010[Diagnostic testing apparatus and instruments for medical use, namely, detectors and analyzers for use in vitro diagnostic testing procedures; medical diagnostic tests kits for professional or home use comprised of collection pads or swabs, collection loops or vials, test strips capable of visual or instrument read out of test results and/or vials of developer solution or reagents, which use oral fluid, finger stick or venipuncture whole blood, plasma, serum, and other bodily fluids and specimens for use in detecting antibodies, antigen, viruses, diseases, nucleic acids, pathogens, proteins, toxins and chemicals]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2018NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Apr 12, 2018RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Apr 12, 201889AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Apr 10, 2018E89RTEAS SECTION 8 & 9 RECEIVED—
Feb 12, 2017REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Feb 26, 2014NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 26, 2014C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 26, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 11, 2014815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Feb 11, 2014E815TEAS SECTION 8 & 15 RECEIVED—
Feb 12, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2008DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jan 8, 2008IUCNNOTICE OF ALLOWANCE CANCELLED—
Dec 19, 2007D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Dec 4, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 19, 2007ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jul 5, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 5, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2007NPUBNOTICE OF PUBLICATION—
Apr 5, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 4, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 3, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 3, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 3, 2007ALIEASSIGNED TO LIE—
Feb 27, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2006DOCKASSIGNED TO EXAMINER—
Apr 21, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance